Using an electronic medical record to identify opportunities to improve compliance with cholesterol guidelines
Journal of General Internal MedicinePublished 1 August 2001Open access
Saverio M. Maviglia, Jonathan M. Teich, Julie Fiskio, David W. Bates
Citations52
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Poor compliance with nationally published and well-accepted guidelines on diagnosing and treating hypercholesterolemia in secondary prevention patients was found, especially low for women, African Americans, patients without a cardiologist, and patients with cerebrovascular and peripheral vascular disease.
Abstract
We found poor compliance with nationally published and well-accepted guidelines on diagnosing and treating hypercholesterolemia in secondary prevention patients. Compliance was unrelated to physician or physician-specific characteristics, but it was especially low for women, African Americans, patients without a cardiologist, and patients with cerebrovascular and peripheral vascular disease.
Keywords
Medicine
JAMASummary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
27,886 Citations1993Scott M. Grundy
Dairy therapy remains the first line of treatment of high blood cholesterol, and drug therapy is reserved for patients who are considered to be at high risk for CHD, and the fundamental approach to treatment is comparable.
New England Journal of MedicineThe Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
7,491 Citations1996Frank M. Sacks, Marc A. Pfeffer +10 more
It is demonstrated that the benefit of cholesterol-lowering therapy extends to the majority of patients with coronary disease who have average cholesterol levels and was also greater in patients with higher pretreatment levels of LDL cholesterol.
JAMAWhy Don't Physicians Follow Clinical Practice Guidelines?
6,528 Citations1999Michael D. Cabana, Cynthia S. Rand +5 more
A differential diagnosis for why physicians do not follow practice guidelines is offered, as well as a rational approach toward improving guideline adherence and a framework for future research are offered.
JAMAWhat's the Relative Risk?
3,993 Citations1998Jun Zhang, Kai Yu
This work proposes a simple method to approximate a risk ratio from the adjusted odds ratio and derive an estimate of an association or treatment effect that better represents the true relative risk.
BMJCollaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
3,125 Citations1994Antiplatelet Trialists' Collaboration
There was no appreciable evidence that either a higher aspirin dose or any other antiplatelet regimen was more effective than medium dose aspirin in preventing vascular events, so in each of the four main high risk categories overall mortality was significantly reduced.
The LancetEffect of clinical guidelines on medical practice: a systematic review of rigorous evaluations
2,811 Citations1993Jeremy Grimshaw, Ian Russell
It is concluded that explicit guidelines do improve clinical practice, when introduced in the context of rigorous evaluations, however, the size of the improvements in performance varied considerably.
The LancetRandomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
2,395 Citations1994SCANDINAVIANSIMVASTATINSURVIVAL
This study shows that long-term treatment with simvastatin is safe and improves survival in CHD patients, and a 37% reduction in the risk of undergoing myocardial revascularisation procedures.
New England Journal of MedicineRegression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
2,166 Citations1990Greg Brown, John J. Albers +8 more
In men with coronary artery disease who were at high risk for cardiovascular events, intensive lipid-lowering therapy reduced the frequency of progression of coronary lesions, increased the frequencyof regression, and reduced the incidence of cardiovascular events.
BMJbeta Blockade after myocardial infarction: systematic review and meta regression analysis
1,494 Citations1999Nick Freemantle, John G.F. Cleland +3 more
β Blockers are effective in long term secondary prevention after myocardial infarction, but they are underused in such cases and lead to avoidable mortality and morbidity.
New England Journal of MedicineDifferences in the Use of Procedures between Women and Men Hospitalized for Coronary Heart Disease
1,192 Citations1991John Z. Ayanian, Arnold M. Epstein
It is demonstrated that women who are hospitalized for coronary heart disease undergo fewer major diagnostic and therapeutic procedures than men.
New England Journal of MedicineThe Effect of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation on Obstructive Changes in Saphenous-Vein Coronary-Artery Bypass Grafts
970 Citations1997The Post Coronary Artery Bypass Graft Trial Investigators
Aggressive lowering of LDL cholesterol levels to below 100 mg per deciliter reduced the progression of atherosclerosis in grafts and low-dose warfarin did not reduce the progression in patients with aortocoronary bypass grafts.
PubMedCollaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
759 Citations1994
Reductions in vascular events were separately statistically significant in middle age and old age, in men and women, in hypertensive and normotensive patients, and in diabetic and nondiabetic patients, suggesting that longer treatment might well be more effective.
New England Journal of MedicineRacial Variation in the Use of Coronary-Revascularization Procedures — Are the Differences Real? Do They Matter?
551 Citations1997Eric D. Peterson, Linda K. Shaw +4 more
Blacks with coronary disease were significantly less likely than whites to undergo coronary revascularization, particularly bypass surgery - a difference that could not be explained by the clinical features of their disease.
Archives of Internal MedicineLipoproteins, Cardiovascular Disease, and Death
528 Citations1981Tavia Gordon
Based on six years of follow-up evaluations of the Framingham, Mass, men and women aged 49 to 82 years, a low-density lipoprotein (LDL) cholesterol concentration was associated with a low incidence of coronary heart disease (CHD) risk but with a statistically significant excess of stroke incidence in women and of deaths from non-CHD causes in both sexes.
BMJISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither
405 Citations1998Colin Baigent, R. Collins +4 more
The early survival advantages produced by fibrinolytic therapy and one month of aspirin started in acute myocardial infarction seem to be maintained for at least 10 years, and the early benefit obtained with combination of streptokinase and oneMonth aspirin also seemed to persist long term.
JAMARacial Differences in the Use of Revascularization Procedures After Coronary Angiography
401 Citations1993John Z. Ayanian
Among Medicare enrollees, whites are more likely than blacks to receive revascularization procedures after coronary angiography and these differences may reflect overuse in whites or underuse in blacks, but they are unlikely to reflect access to cardiologists or hospitals that perform revascularized procedures.
CirculationAn analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence.
246 Citations1990Ingar Holme
This study shows that cholesterol reduction is effective in lowering CHD incidence, but cholesterol reduction must be at least 8-9% to beeffective in lowering total mortality.
JAMAInfluence of Race, Sex, and Age on Management of Unstable Angina and Non—Q-Wave Myocardial Infarction
238 Citations1996Peter H. Stone
Among patients presenting with acute ischemic chest pain without persistent ST-segment elevation, blacks appeared to have less severe coronary disease, received revascularization less frequently, and had less recurrent ischemia compared with nonblacks.
JAMAThe Association of Payer With Utilization of Cardiac Procedures in Massachusetts
200 Citations1990Mark B. Wenneker
It is found that insurance status is associated with the utilization of cardiac procedures, and the odds that privately insured patients received angiography were 80% higher than uninsured patients; the odds were higher for bypass grafting and 28% higher for angioplasty.
The American Journal of MedicineInadequate treatment with HMG-CoA reductase inhibitors by health care providers
168 Citations1996Jennifer J. Marcelino, Kenneth R. Feingold
Based on the current NCEP recommendations, patients on monotherapy with HMG-CoA reductase inhibitors are often inadequately treated and less than half of the patients were adequately monitored for hepatotoxicity.
PubMedInfluence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry.
117 Citations1996Peter H. Stone, Bruce Thompson +14 more
Clinical BiochemistryEstimation of LDL cholesterol based on the Friedewald formula and on apo B levels
92 Citations2000Eleni Bairaktari, Katerina Hatzidimou +6 more
The LDL-B formula is a more reliable and accurate method than the LDL-F formula, especially at TG levels >2.26 mmol/L, although it underestimates LDL-C concentrations, and can be used in hypertriglyceridemic patients in whom the Friedewald equation is inaccurate.
Journal of Internal MedicineGuidelines and reported practice for the treatment of hypertension and hypercholesterolaemia
26 Citations1997Margareta Troein, Bertil Gardell +2 more
These guidelines and reported practice for the treatment of hypertension and hypercholesterolaemia are published for the first time.
PubMedThe use of beta-blockers after myocardial infarction.
26 Citations1983Zoltan G. Turi, Eugene Braunwald
Journal of General Internal MedicinePrimary care clinician compliance with cholesterol treatment guidelines
24 Citations1991Joel M. Schectman, Elaine G. Elinsky +1 more
Compliance with National Cholesterol Education Panel guidelines for dietary counseling, but not drug therapy, was higher in this setting than in other published compliance studies.
JAMAThe Use of β-Blockers After Myocardial Infarction
18 Citations1983Zoltan G. Turi
The concept of prevention of reinfarction and death after myocardial infarction, ie, secondary prevention, has been actively investigated for the past two decades and almost all efforts at demonstrating secondary prevention had failed.